Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124950) titled 'Prognostic Prediction of Hepatocellular Carcinoma Invasiveness Based on CEMRI Combined Habitat Analysis' on May 19.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Chengdu Qingyang District Traditional Chinese Medicine Hospital

Condition: Hepatocellular carcinoma

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-01

Target Sample Size: Test set & Training set & Validation set:300;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=314847

Published by HT Digital Content Services with permission fro...